Literature DB >> 19805970

Leiomyosarcoma of the renal pelvis.

Sagar A Dhamne1, Nitin M Gadgil, Anita Padmanabhan.   

Abstract

Leiomyosarcomas are rare malignant tumors of the kidney. They may arise from the renal capsule, renal vein, renal pelvic musculature or renal parenchyma. Renal pelvis is an uncommon site of occurrence, with around 10 cases reported in the literature so far. Here we present a 60-year-old male who presented with increased urinary frequency, lower limb weakness, anorexia and weight loss. Imaging showed a right renal mass. A renal cell carcinoma was suspected clinically. A right nephrectomy was performed, which showed a large circumscribed mass in the hilar region. Histology revealed a tumor mass arising from the renal pelvis. The tumor was composed of spindle cells arranged in fascicles. Immunohistochemistry showed tumor cells to be positive for smooth muscle actin (SMA) and desmin (Des) and negative for cytokeratin (CK), HMB 45, CD117 (C-kit), and CD34. That confirmed the diagnosis of leiomyosarcoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19805970     DOI: 10.4103/0377-4929.56161

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  3 in total

1.  Recurrent renal leiomyosarcoma mimicking a colonic submucosal tumor: a case report.

Authors:  Yun Jeung Kim; Hee Seok Moon; Eaum Seok Lee; Jae Kyu Sung; Hyun Yong Jeong; Ji Yeon Kim; Dae Young Kang
Journal:  J Korean Soc Coloproctol       Date:  2011-10-31

2.  Leiomyosarcoma of the renal vein: analysis of outcome and prognostic factors in the world case series of 67 patients.

Authors:  Marko Novak; Andraz Perhavec; Katherine E Maturen; Snezana Pavlovic Djokic; Simona Jereb; Darja Erzen
Journal:  Radiol Oncol       Date:  2016-12-23       Impact factor: 2.991

3.  Primary Ewing sarcoma/primitive neuroectodermal tumor of the renal pelvis: a case report.

Authors:  Zhihong Liu; Xianding Wang; You Lu; Libo Chen; Yiping Lu
Journal:  World J Surg Oncol       Date:  2014-09-22       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.